News | January 20, 2022
SEC recommends regular market approval for Covishield and Covaxin
However, these won’t be available at the nearest chemist store soon
However, these won’t be available at the nearest chemist store soon
Ram’s appointment follows the launch of the CDI India division in October 2021.
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
Yoga helps to build a strong immune system and daily breathing regime of 10-minute helps in the long run
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Dr Woler joins Sygnature Discovery after the company received significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co, in 2021
The global multi-center phase-II clinical trial will be a 36-week, multi-center, randomized, double-blind, placebo-controlled trial, followed by a 36-week open-label extension period
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson's disease
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
